These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4617836)

  • 1. [Report on the clinical testing of Cormelian-Digotab].
    Pollter J
    Med Welt; 1974 Nov; 25(48):2015-21. PubMed ID: 4617836
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of coronary heart disease using Cormelian-Digotab. Results of a double blind study].
    Messerich J
    Fortschr Med; 1974 Nov; 92(33):1367-71. PubMed ID: 4457447
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cormelian (Dilazep) a new coronary active substance].
    Reuter H
    Z Allgemeinmed; 1974 Oct; 50(28):1255-6. PubMed ID: 4614598
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of coronary heart disease using Cormelian-Digotab. First communication on a field experiment of 107 residential physicians].
    Pollter J; Schnitker J
    Med Welt; 1975 Oct; 26(44):2007-12. PubMed ID: 1186488
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tolerance and effectiveness of Cormelian in patients with coronary disease].
    Messerich J
    Med Welt; 1972 Apr; 23(15):563-6. PubMed ID: 5038526
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of therapy-resistant stenocardias associated with myocardial insufficiency using cormelian-digotab in a rehabilitation clinic].
    Koeffler H
    Fortschr Med; 1974 Dec; 92(35-36):1458-61. PubMed ID: 4435699
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of coronary heart disease using Cormelian-Digotab: influence of the duration of therapy. 2. Field study by 107 physicians].
    Pollter J; Schnitker J
    Med Welt; 1976 Oct; 27(43):2074-9. PubMed ID: 792623
    [No Abstract]   [Full Text] [Related]  

  • 8. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 3. Influence of the duration of therapy and co-medication on the therapeutic result. Secondary effects and discontinuation of therapy].
    Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1873-9. PubMed ID: 4155950
    [No Abstract]   [Full Text] [Related]  

  • 9. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 2. The importance of anamnestic and diagnostic characteristics for successful therapy].
    Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1864-72. PubMed ID: 4615714
    [No Abstract]   [Full Text] [Related]  

  • 10. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 4. Results of a summarizing evaluation with factor analysis and multiple regression analysis].
    Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1879-93. PubMed ID: 4155951
    [No Abstract]   [Full Text] [Related]  

  • 11. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 1. Epidemiological situation of coronary heart disease].
    Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1853-64. PubMed ID: 4480270
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results of the clinical testing of a new coronary drug, Cormelian].
    Pollter J
    Fortschr Med; 1972 Apr; 90(10):399-404. PubMed ID: 4616888
    [No Abstract]   [Full Text] [Related]  

  • 13. [New methods of therapy in coronary diseases].
    Hohenstein H
    Ther Ggw; 1965 Sep; 104(9):1242-8. PubMed ID: 5323652
    [No Abstract]   [Full Text] [Related]  

  • 14. [Efficiency of Cormelian in coronary insufficiency. Results of a double-blind study].
    Gillner H; Pollter J; Schnitker J; Sievers HG; Zylmann G
    Med Monatsschr; 1975 Feb; 29(2):82-7. PubMed ID: 1092990
    [No Abstract]   [Full Text] [Related]  

  • 15. [Further progress in the treatment of the coronary disease].
    Pillen D
    Med Welt; 1976 Mar; 27(12):581-5. PubMed ID: 772355
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of a multicenter study on the new coronary vasodilator agent Sensit].
    Meza E; Orozco-Mafud A
    Prensa Med Mex; 1977; 42(1-2):78-83. PubMed ID: 331301
    [No Abstract]   [Full Text] [Related]  

  • 17. [Polycentric and hemodynamic experimentation with a new coronary active drug: dilazep].
    Baldrighi V; Barbaresi F; Plancher AC; Portioli I
    Clin Ter; 1976 Aug; 78(4):303-62. PubMed ID: 795597
    [No Abstract]   [Full Text] [Related]  

  • 18. [Review of the literature and report of experiments relating to the coronaroactive drug, hexobendine].
    Marmo E; Caputi AP; Cataldi S
    Minerva Cardioangiol; 1972 Oct; 20(10):571-81. PubMed ID: 4562623
    [No Abstract]   [Full Text] [Related]  

  • 19. [Gradulon in the treatment of heart insufficiency with simultaneous cardiocirculatory load].
    Grossmann D; Mishra BR
    Med Welt; 1974 May; 25(22):1006-9. PubMed ID: 4605687
    [No Abstract]   [Full Text] [Related]  

  • 20. [Carbochromen in treatment of coronary arterial disease].
    Szczepański L; Wnukowska M; Dmoszyńska A
    Wiad Lek; 1974 Mar; 27(5):463-6. PubMed ID: 4603373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.